IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
1.015
+0.010 (1.00%)
At close: Jun 6, 2025, 4:00 PM
1.030
+0.015 (1.48%)
After-hours: Jun 6, 2025, 6:41 PM EDT
IceCure Medical Employees
As of December 31, 2024, IceCure Medical had 66 total employees, including 64 full-time and 2 part-time employees. The number of employees decreased by 11 or -14.29% compared to the previous year.
Employees
66
Change (1Y)
-11
Growth (1Y)
-14.29%
Revenue / Employee
$49,591
Profits / Employee
-$231,773
Market Cap
59.50M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 66 | -11 | -14.29% |
Dec 31, 2023 | 77 | 5 | 6.94% |
Dec 31, 2022 | 72 | 8 | 12.50% |
Dec 31, 2021 | 64 | 17 | 36.17% |
Dec 31, 2020 | 47 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ICCM News
- 10 days ago - IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - IceCure Medical Reports First Quarter 2025 Financial Results - PRNewsWire
- 17 days ago - IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025 - PRNewsWire
- 4 weeks ago - IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation - PRNewsWire
- 5 weeks ago - IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer - PRNewsWire
- 5 weeks ago - IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium - PRNewsWire
- 6 weeks ago - IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation - PRNewsWire
- 2 months ago - IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript - Seeking Alpha